Locations:
Search IconSearch

Research

Doctor with overweight older adult

Managing Obesity in Older Adults

Challenges include multimorbidity, polypharmacy, limited mobility and sarcopenia

Woman's hands holding drug injector

Cost, Side Effects Top Reasons for Quitting GLP-1s for Obesity

Data could help inform policy and patient-provider conversations

hospitalized woman talking to her doctor

Diagnosing Insulinomas: Beta-Hydroxybutyrate Protocol Reduces Fasting Time

Patients spent less time in the hospital and no tumors were missed

Twin images of woman holding smart phone; second images has lots of imagery of a digital matrix in background.

Randomized Clinical Trial Demonstrates AI-Supported Coaching Program Improved Outcomes in Patients with T2D

A new study shows that an AI-enabled bundled system of sensors and coaching reduced A1C with fewer medications

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Physician consulting with patient on weight management

Comparing Obesity-Centric Approach and Usual Care in T2D and Obesity

A weight-management program plus anti-obesity medication performs well

person injecting insulin

De-Intensification From Basal Bolus to Subcutaneous Semaglutide and Basal Insulin

TRANSITION-T2D RCT results for patients with T2D receiving MDI

Checkpoint inhibitors

Endocrinopathies from Checkpoint Inhibitors

Incidence, outcomes and management

Keren Zhou, MD

Multi-Pronged Strategies Key to Reducing Hospital-Related Hyperglycemic Events

Cleveland Clinic endocrinologists work to identify protocols for improving care

Blood test
February 10, 2023/COVID-19

Effects of COVID-19 on Blood Sugar and Type 2 Diabetes

Cleveland Clinic analysis suggests that obtaining care for the virus might reveal a previously undiagnosed condition

kidneys and diabetes

Kidney Disease in Diabetes: Updates and Recommendations

Cleveland Clinic’s Endocrinology & Metabolism Institute is working to offer novel opportunities and therapies for diabetes and kidney disease

BackPage 1 of 5Next

Advertisement

Ad